Skip to main content
. 2020 Oct 6;4(19):4802–4811. doi: 10.1182/bloodadvances.2020002183

Table 3.

AEs (≥15%) for patients in part 2

Preferred term All grades, n (%) Grade ≥3, n (%)
CLL/SLL (n = 45)
 Upper respiratory tract infection 23 (51.1) 0
 Neutropenia 20 (44.4) 14 (31.1)
 Contusion 15 (33.3) 0
 Cough 12 (26.7) 0
 Diarrhea 12 (26.7) 0
 Fatigue 12 (26.7) 1 (2.2)
 Pyrexia 10 (22.2) 0
 Petechiae 8 (17.8) 0
 Rash maculopapular 8 (17.8) 0
 Sinusitis 8 (17.8) 0
 Thrombocytopenia 8 (17.8) 3 (6.7)
 Back pain 7 (15.6) 2 (4.4)
 Dyspepsia 7 (15.6) 0
 Nausea 7 (15.6) 0
 Pneumonia 7 (15.6) 4 (8.9)
 Rash 7 (15.6) 0
R/R FL (n = 36)
 Upper respiratory tract infection 14 (38.9) 0
 Contusion 10 (27.8) 0
 Fatigue 9 (25.0) 0
 Cough 8 (22.2) 0
 Nausea 7 (19.4) 0
 Rash 7 (19.4) 0
 Thrombocytopenia 7 (19.4) 2 (5.6)
 Diarrhea 6 (16.7) 0
 Neutropenia 6 (16.7) 5 (13.9)
 Petechiae 6 (16.7) 0
 Productive cough 6 (16.7) 0